ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Preoperative Methylprednisolone Enhances Recovery After Endovascular Aortic Repair: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Thursday, August 14, 2014

Submitted by

Author(s)

de la Motte, Louise; Kehlet, Henrik; Vogt, Katja; Nielsen, Claus H.; Groenvall, John B.; Nielsen, Henning B.; Andersen, Andreas; Schroeder, Torben V.; Lönn, Lars

This double-blind placebo-controlled trial involved 153 pts undergoing elective endovascular aortic aneurysm repair, of whom half received methylprednisolone preoperatively.  The intervention reduced the systemic inflammatory response from 92% to 27%, plasma IL-6 was decreased by 90%, and CRP, body temperature, IL-8, and TNF were also reduced.  MMP-9, D-dimer, and myeloperoxidase were unchanged.  Medical and surgical morbidity were similar between the groups.  The intervention reduced time to meet discharge criteria from 3 to 2 days.

Add comment

Log in or register to post comments